1. Home
  2. ADAP vs RVSN Comparison

ADAP vs RVSN Comparison

Compare ADAP & RVSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • RVSN
  • Stock Information
  • Founded
  • ADAP 2008
  • RVSN 2016
  • Country
  • ADAP United Kingdom
  • RVSN Israel
  • Employees
  • ADAP N/A
  • RVSN N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • RVSN
  • Sector
  • ADAP Health Care
  • RVSN
  • Exchange
  • ADAP Nasdaq
  • RVSN Nasdaq
  • Market Cap
  • ADAP 21.3M
  • RVSN 20.5M
  • IPO Year
  • ADAP 2015
  • RVSN 2022
  • Fundamental
  • Price
  • ADAP $0.07
  • RVSN $0.37
  • Analyst Decision
  • ADAP Hold
  • RVSN
  • Analyst Count
  • ADAP 6
  • RVSN 0
  • Target Price
  • ADAP $1.02
  • RVSN N/A
  • AVG Volume (30 Days)
  • ADAP 63.5M
  • RVSN 1.2M
  • Earning Date
  • ADAP 11-12-2025
  • RVSN 08-22-2025
  • Dividend Yield
  • ADAP N/A
  • RVSN N/A
  • EPS Growth
  • ADAP N/A
  • RVSN N/A
  • EPS
  • ADAP N/A
  • RVSN N/A
  • Revenue
  • ADAP $65,084,999.00
  • RVSN $776,000.00
  • Revenue This Year
  • ADAP N/A
  • RVSN $1,861.54
  • Revenue Next Year
  • ADAP $52.35
  • RVSN N/A
  • P/E Ratio
  • ADAP N/A
  • RVSN N/A
  • Revenue Growth
  • ADAP N/A
  • RVSN N/A
  • 52 Week Low
  • ADAP $0.04
  • RVSN $0.27
  • 52 Week High
  • ADAP $1.12
  • RVSN $2.72
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 44.99
  • RVSN 47.34
  • Support Level
  • ADAP $0.06
  • RVSN $0.35
  • Resistance Level
  • ADAP $0.07
  • RVSN $0.39
  • Average True Range (ATR)
  • ADAP 0.01
  • RVSN 0.03
  • MACD
  • ADAP 0.01
  • RVSN -0.00
  • Stochastic Oscillator
  • ADAP 88.67
  • RVSN 25.00

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About RVSN Rail Vision Ltd.

Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.

Share on Social Networks: